s6y
Company name or ticker
Search
X4 Pharmaceuticals, Inc
ARS
Annual report to security holders
Filed
Monday, April 29, 2024
Period
Dec 31, 2023
Accession number
0001628280-24-019063
Documents
ARS
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header